A role for carbohydrates in immune evasion in AIDS
- PMID: 9623976
- DOI: 10.1038/nm0698-679
A role for carbohydrates in immune evasion in AIDS
Abstract
Rhesus monkeys were infected with mutant forms of simian immunodeficiency virus lacking dual combinations of the 4th, 5th and 6th sites for N-linked glycosylation in the external envelope glycoprotein of the virus. When compared with sera from monkeys infected with the parental virus, sera from monkeys infected with the mutant viruses exhibited markedly increased antibody binding to specific peptides from this region and markedly increased neutralizing activity. These results demonstrate a role for N-linked glycosylation in limiting the neutralizing antibody response to SIV and in shielding the virus from immune recognition.
Similar articles
-
Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.J Virol. 1993 Jul;67(7):4104-13. doi: 10.1128/JVI.67.7.4104-4113.1993. J Virol. 1993. PMID: 8510218 Free PMC article.
-
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.J Virol. 1998 Jan;72(1):585-92. doi: 10.1128/JVI.72.1.585-592.1998. J Virol. 1998. PMID: 9420262 Free PMC article.
-
Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.J Virol. 2000 Mar;74(6):2960-5. doi: 10.1128/jvi.74.6.2960-2965.2000. J Virol. 2000. PMID: 10684319 Free PMC article.
-
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.J Virol. 2001 Apr;75(8):3903-15. doi: 10.1128/JVI.75.8.3903-3915.2001. J Virol. 2001. PMID: 11264379 Free PMC article.
-
Dissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization.Immunol Res. 2006;36(1-3):51-60. doi: 10.1385/IR:36:1:51. Immunol Res. 2006. PMID: 17337766 Free PMC article. Review.
Cited by
-
Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.Adv Pharmacol. 2007;55:33-97. doi: 10.1016/S1054-3589(07)55002-7. Adv Pharmacol. 2007. PMID: 17586312 Free PMC article. Review.
-
Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro.J Virol. 2001 Sep;75(18):8868-73. doi: 10.1128/jvi.75.18.8868-8873.2001. J Virol. 2001. PMID: 11507234 Free PMC article.
-
Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.J Virol. 2002 Oct;76(20):10299-306. doi: 10.1128/jvi.76.20.10299-10306.2002. J Virol. 2002. PMID: 12239306 Free PMC article.
-
Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.J Virol. 2002 Dec;76(24):12855-65. doi: 10.1128/jvi.76.24.12855-12865.2002. J Virol. 2002. PMID: 12438611 Free PMC article.
-
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.J Virol. 2006 Oct;80(19):9586-98. doi: 10.1128/JVI.00141-06. J Virol. 2006. PMID: 16973562 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical